Agarwal S, Sharma MC, Jha P et al (2013) Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing. Neuro Oncol 15(6):718–726. https://doi.org/10.1093/neuonc/not015

CAS  Article  PubMed  PubMed Central  Google Scholar 

Claus EB, Walsh KM, Wiencke JK et al (2015) Survival and low-grade glioma: the emergence of genetic information. Neurosurg Focus 38(1):E6. https://doi.org/10.3171/2014.10.FOCUS12367

Article  PubMed  PubMed Central  Google Scholar 

Deguchi S, Oishi T, Mitsuya K et al (2020) Clinicopathological analysis of T2-FLAIR mismatch sign in lower-grade gliomas. Sci Rep 10(1):10113. https://doi.org/10.1038/s41598-020-67244-7

CAS  Article  PubMed  PubMed Central  Google Scholar 

Eckel-Passow JE, Lachance DH, Molinaro AM et al (2015) Glioma groups based on 1p/19q, IDH, and TERT promoter mutations in tumors. N Engl J Med 372(26):2499–2508. https://doi.org/10.1056/NEJMoa1407279

CAS  Article  PubMed  PubMed Central  Google Scholar 

Eibl RH, Schneemann M (2021) Liquid biopsy and primary brain tumors. Cancers (Basel). https://doi.org/10.3390/cancers13215429

Article  Google Scholar 

Goyal A, Yolcu YU, Goyal A et al (2019) The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance. Neurosurg Focus 47(6):E13. https://doi.org/10.3171/2019.9.FOCUS19660

Article  PubMed  Google Scholar 

Jary H, Rylance J, Patel L, Gordon SB, Mortimer K (2015) Comparison of methods for the analysis of airway macrophage particulate load from induced sputum, a potential biomarker of air pollution exposure. BMC Pulm Med 15:137. https://doi.org/10.1186/s12890-015-0135-7

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jebali A, Dumaz N (2018) The role of RICTOR downstream of receptor tyrosine kinase in cancers. Mol Cancer 17(1):39. https://doi.org/10.1186/s12943-018-0794-0

CAS  Article  PubMed  PubMed Central  Google Scholar 

Jian A, Jang K, Manuguerra M, Liu S, Magnussen J, Di Ieva A (2021) Machine learning for the prediction of molecular markers in glioma on magnetic resonance imaging: a systematic review and meta-analysis. Neurosurgery 89(1):31–44. https://doi.org/10.1093/neuros/nyab103

Article  PubMed  Google Scholar 

Kinoshita M, Uchikoshi M, Sakai M, Kanemura Y, Kishima H, Nakanishi K (2021) t(2)-FLAIR mismatch sign is caused by long t(1) and t(2) of IDH-mutant, 1p19q non-codeleted astrocytoma. Magn Reson Med Sci 20(1):119–123. https://doi.org/10.2463/mrms.bc.2019-0196

CAS  Article  PubMed  Google Scholar 

Lass U, Hartmann C, Capper D et al (2013) Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Brain Pathol 23(3):311–318. https://doi.org/10.1111/bpa.12003

CAS  Article  PubMed  Google Scholar 

Liu Y, Lu Y, Li A et al (2020) mTORC2/Rac1 pathway predisposes cancer aggressiveness in IDH1-mutated glioma. Cancers (Basel). https://doi.org/10.3390/cancers12040787

Article  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  PubMed  Google Scholar 

Louis DN, Wesseling P, Aldape K et al (2020) cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. Brain Pathol 30(4):844–856. https://doi.org/10.1111/bpa.12832

Article  PubMed  PubMed Central  Google Scholar 

Makino Y, Arakawa Y, Yoshioka E, Miyamoto S et al (2021) Prognostic stratification for IDH-wild-type lower-grade astrocytoma by Sanger sequencing and copy-number alteration analysis with MLPA. Sci Rep 11(1):14408. https://doi.org/10.1038/s41598-021-93937-8

CAS  Article  PubMed  PubMed Central  Google Scholar 

Nicholson C, Hrabětová S (2017) Brain extracellular space: the final frontier of neuroscience. Biophys J 113(10):2133–2142. https://doi.org/10.1016/j.bpj.2017.06.052

CAS  Article  PubMed  PubMed Central  Google Scholar 

Onishi S, Amatya VJ, Kolakshyapati M et al (2020) T2-FLAIR mismatch sign in dysembryoplasticneuroepithelial tumor. Eur J Radiol 126:108924. https://doi.org/10.1016/j.ejrad.2020.108924

Article  PubMed  Google Scholar 

Park SI, Suh CH, Guenette JP, Huang RY, Kim HS (2021) The T2-FLAIR mismatch sign as a predictor of IDH-mutant, 1p/19q-noncodeleted lower-grade gliomas: a systematic review and diagnostic meta-analysis. Eur Radiol 31(7):5289–5299. https://doi.org/10.1007/s00330-020-07467-4

CAS  Article  PubMed  Google Scholar 

Patel SH, Poisson LM, Brat DJ et al (2017) T2-FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: a TCGA/TCIA Project. Clin Cancer Res 23(20):6078–6085. https://doi.org/10.1158/1078-0432.CCR-17-0560

CAS  Article  PubMed  Google Scholar 

Pinto C, Noronha C, Taipa R, Ramos C (2022) T2-FLAIR mismatch sign: a roadmap of pearls and pitfalls. Br J Radiol 95(1129):20210825. https://doi.org/10.1259/bjr.20210825

Article  PubMed  Google Scholar 

Pollo B (2011) Neuropathological diagnosis of brain tumours. Neurol Sci 32(suppl 2):S209–S211. https://doi.org/10.1007/s10072-011-0802-2

Article  PubMed  Google Scholar 

Sun H, Yin L, Li S et al (2013) Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis. J Neurooncol 113(2):277–284. https://doi.org/10.1007/s11060-013-1107-5

CAS  Article  PubMed  Google Scholar 

Tay KL, Tsui A, Phal PM, Drummond KJ, Tress BM (2011) MR imaging characteristics of protoplasmic astrocytomas. Neuroradiology 53(6):405–411. https://doi.org/10.1007/s00234-010-0741-2

Article  PubMed  Google Scholar 

van den Bent MJ, Smits M, Kros JM, Chang SM (2017) Diffuse infiltrating oligodendroglioma and astrocytoma. J Clin Oncol 35(21):2394–2401. https://doi.org/10.1200/JCO.2017.72.6737

Article  PubMed  Google Scholar 

Weller M, Weber RG, Willscher E et al (2015) Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol 129(5):679–693. https://doi.org/10.1007/s00401-015-1409-0

CAS  Article  PubMed  Google Scholar 

Yamashita S, Yokogami K, Matsumoto F et al (2018) MGMT promoter methylation in patients with glioblastoma: is methylation-sensitive high-resolution melting superior to methylation-sensitive polymerase chain reaction assay? J Neurosurg 130(3):780–788. https://doi.org/10.3171/2017.11.JNS171710

Article  PubMed  Google Scholar 

Yokogami K, Yamasaki K, Matsumoto F et al (2018) Impact of PCR-based molecular analysis in daily diagnosis for the patient with gliomas. Brain Tumor Pathol 35(3):141–147. https://doi.org/10.1007/s10014-018-0322-3

CAS  Article  PubMed  Google Scholar